TCON - 3 Things In Biotech You Should Learn Today: January 24 2018
Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication.
Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotechnology research.
Bristol-Myers expands Yervoy in Europe
Company: Bristol-Myers Squibb (BMY)
Therapy: Ipilimumab
Disease: Advanced or metastatic melanoma
News: BMY announced that the European Commission has approved the expanded use of ipilimumab (branded Yervoy) in Europe to include treatment of patients as young as 12, echoing similar approval